Top Markets
#1 Akedo Akedo +60.74%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.99%
#4 Velvet Velvet +41.93%
#5 Black Phoenix Black Phoenix +34.52%
#6 τemplar τemplar +26.67%
#7 Ribbita by Virtuals Ribbita by Virtuals +18.82%
#8 Bitway Bitway +17.19%
#9 Cap Cap +17.11%
#10 Perle Perle +15.44%
Coin of the day
Akedo Akedo
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
CohBar, Inc. CohBar, Inc.

CohBar, Inc.

CWBR
शेयरों में रैंक #38304
CohBar Inc. is a clinical-stage biotechnology company dedicated to the... CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging. These MBTs are being developed to address a broad spectrum of medical challenges, including non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis (IPF), type 2 diabetes, acute respiratory distress syndrome (ARDS), various cancers, and cardiovascular disorders like Alzheimer's disease. Their flagship clinical asset is CB4211, an innovative, optimized analogue of the MOTS-c mitochondrial-derived peptide. This candidate is currently undergoing Phase Ib evaluation as part of a larger Phase Ia/Ib clinical trial, specifically targeting non-alcoholic steatohepatitis (NASH) and obesity. Beyond their clinical work, CohBar's preclinical portfolio features CB5138 analogs aimed at fibrotic conditions, as well as CB5064 analogs being explored for their potential in treating ARDS linked to COVID-19. Established in 2007, CohBar, Inc. maintains its corporate headquarters in Menlo Park, California.
शेयर मूल्य
$0.41
अंतिम समन्वयन: 2025-01-23
मार्केट कैप
$1.08M
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार CohBar, Inc. (CWBR)

श्रेणी

Healthcare
CohBar, Inc. (CWBR) के लिए P/B अनुपात
August 2026 को P/B अनुपात TTM: 0.08
CohBar, Inc. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/B अनुपात (TTM) 0.08 है। 2021 के अंत में, कंपनी का P/B अनुपात 0.91 था।
CohBar, Inc. के लिए 2011 से 2026 तक P/B अनुपात का इतिहास
हर वर्ष के अंत में P/B अनुपात
वर्ष P/B अनुपात परिवर्तन
2026 (TTM) 0.08 -75.78%
2022 0.32 -64.70%
2021 0.91 -74.27%
2020 3.54 -57.97%
2019 8.42 17.87%
2018 7.14 -70.78%
2017 24.44 213.13%
2016 7.81 115.36%
2015 3.62 -84.35%
2014 23.15 -103.81%
2013 -607.96 -3,077.68%
2012 20.42 0.00%
2011 0.00 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए P/B अनुपात
कंपनी P/B अनुपात P/B अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 7,979.10%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 8,091.35%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 4,589.03%
BE